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Abstract
Previous studies have shown that foamy virus (FV) particle budding, especially the involvement of the viral Env glycoprotein, is different
from that of other (ortho) retroviruses: the N-terminal Env leader protein Elp is a constituent of released FV particles. A defined sequence
in Elp required for particle budding binds to the MA domain of Gag. To extend these findings, we show that feline FV Elp is a
membrane-anchored protein with the N-terminus located inside the particle. Thus, the internal/cytoplasmic domain of Elp has the correct
topology for interacting with Gag during budding. In addition to Elp, an Elp-related protein of about 9 kDa was shown to be virion associated
and is probably generated by cellular signal peptidases. Besides the function of Elp binding, the N-terminal domain of Gag was shown to
be required for proper localization of feline FV Gag to the cytoplasm and the perinuclear/nuclear region.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Research on the biology of spuma or foamy viruses (FV)
has gained increasing interest since these retroviruses are
considered as potent potential vectors for the transfer and
expression of genes in cells and organs (Josephson et al.,
2002). Different studies on the molecular biology of FVs
have shown that FVs are unconventional retroviruses em-
ploying mechanisms that set them apart from other retrovi-
ruses but which are used in different virus families, for
instance the hepadnaviruses (Lecellier and Saib, 2000;
Linial, 1999; Lo¨chelt and Flu¨gel, 1996; Rethwilm, 1995).
Although FVs have long been known for their distinct
morphology in thin-section electron microscopy (EM), the
reasons for this difference were not clear (Konvalinka et al.,
1995). During recent years, new insights into the morphol-
ogy and morphogenesis of FVs have been obtained con-
firming that FVs differ also in this aspect from other retro-
viruses (Baldwin and Linial, 1998, 1999; Eastman and
Linial, 2001; Lindemann et al., 2001; Pietschmann et al.,
1999; Wilk et al., 2000, 2001). The Env glycoprotein is
required for FV particle budding, whereas in all other ret-
roviruses, Gag has the intrinsic capacity to direct particle
budding (Pietschmann et al., 1999). In particular, defined
residues of the virion-associated N-terminal Env leader pro-
tein (Elp) of human FV (HFV) have been shown to be
essential (Lindemann et al., 2001). Based on this finding, we
showed for feline FV (FFV) that Elp has the capacity to
interact specifically with N-terminal Gag sequences present
in the novel FV matrix layer (MA-layer; Wilk et al., 2001).
From the results of cryo-EM studies, we concluded that
these interactions occur at the time of budding, possibly
explaining the Env dependence of FV particle release (Wilk
et al., 2001). That such Elp-MA-layer interactions can occur
during FV budding, Elp would have to be located in the
membrane with the N-terminus oriented toward the cytosol
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before budding. After budding, the N-terminus would be
then localized inside the released virus particle. In the
present report, we confirm the internal/cytoplasmic local-
ization of the N-terminal Gag-interacting sequence of the
integral membrane protein Elp. The N-terminal part of FFV
Gag is essential for localization of Gag to the cytoplasm and
perinuclear space that is probably a prerequisite for particle
formation and budding.
Results
The association of FFV Elp to particles is detergent
sensitive
We recently showed that the FFV Elp copurifies with
intact particles in density gradients (Wilk et al., 2001). To
further extend this finding, we determined whether this
association is sensitive toward disruption of the viral mem-
brane by a non-ionic detergent. To this end, released FFV
particles were enriched by sedimentation through a sucrose
cushion, resuspended in phosphate-buffered saline (PBS),
and incubated on ice for 30 min after addition of Triton
X-100 to a final concentration of 0.5%. Finally, the particles
were sedimented into preformed 10 to 32% iodixanol gra-
dients (Wilk et al., 2001). As control, FFV particles not
treated with detergent were analyzed in parallel. Aliquots of
the gradient fractions were analyzed by immunoblotting
using FFV-specific cat serum 8014 (Alke et al., 2000). In
the absence of detergent, the maximum of FFV Gag and Elp
proteins was present in fractions 5 and 6 (Fig. 1A) as
described previously for intact FFV particles (Wilk et al.,
2001). Gag proteins of virions treated with Triton X-100
banded at a higher density corresponding to naked retroviral
particles (Fig. 1B). Upon detergent incubation, Elp no
longer copurified with FFV Gag but remained on top of the
gradient as a soluble protein (Fig. 1B, lanes 1 and 2). This
is indicative of a Triton X-100-mediated disruption of the
viral membrane and subsequent dissociation of the capsids
from the surface proteins (Wilk et al., 2001).
The N-terminal domain of Elp is located inside the FFV
particles
To determine whether the N-terminus of FFV Elp is
inside the virus particle as suggested previously, subtilisin
protease digestions of enriched FFV particles were per-
formed. During subtilisin digestion of enveloped virions,
external proteins are completely digested whereas proteins
inside the particle are protected from proteolytic digestion
by the intact lipid bilayer (Ott et al., 1995). In analogy, the
internal part of a transmembrane protein should be protected
whereas the ectodomain is predicted to be susceptible to
protease-mediated degradation.
Concentrated FFV particles were subjected to subtilisin
digestion as described for human immunodeficiency virus
(HIV) (Ott et al., 1995). Samples taken at defined time
points during digestion were analyzed by immunoblotting
using the FFV Elp-specific antiserum (Wilk et al., 2001).
Upon digestion with subtilisin, the concentration of the
authentic 16-kDa Elp decreased with the concomitant in-
crease of an Elp-specific band of about 9 kDa (Fig. 2, top).
This protein contains the N-terminus of Elp since the anti-
serum used for detection is directed against FFV Env resi-
dues 1–30 (Wilk et al., 2001). The size of the subtilisin-
resistant protein corresponds to the N-terminus of Elp
including a hydrophobic sequence (Fig. 2, bottom, sequence
in boldface letters) most likely representing the transmem-
brane anchor of Elp. Importantly, a 9-kDa Env/Elp-specific
protein is already present at low concentrations in enriched
FFV particles indicating that it is an authentic component of
FFV particles.
No evidence by SPR for a specific interaction of FFV Elp
with Gag peptides 27–58
Arg50 of HFV Gag was recently shown to be essential
for particle formation (Eastman and Linial, 2001). Whereas
the authors assumed that this part of Gag is required for the
appropriate subcellular localization of Gag to allow assem-
bly, we considered that this Gag domain might be directly
involved in Gag-Elp interactions.
Previously we showed by surface plasmon resonance
(SPR) that the 154-residue-long N-terminal sequence of
FFV Gag (Gag 1–154) specifically interacts with peptides
corresponding to the N-terminal 30 amino acids of FFV Elp
or a recombinant Elp 1–65 protein containing the cytoplas-
mic domain of Elp (Wilk et al., 2001). To study the function
of the corresponding Arg43 in FFV Gag, we engineered the
R43A exchange (Arg43 replaced by Ala, see Fig. 3A) into
the recombinant FFV Gag 1–154. The R43A exchange
reduced solubility of the mutant FFV Gag and decreased
concentration and purification by affinity chromatography.
Interaction of the mutant Gag 1-154-R43A with the immo-
bilized Elp 1–65 was detectable by SPR, however, the
binding kinetics were not indicative for a high affinity and
specific association whereas unmodified Gag 1–154 resulted
in specific and strong signals (data not shown).
To circumvent these problems possibly related to solu-
bility and proper folding of the mutant Gag, we determined
whether the FFV Gag-derived peptide 27–58 (Fig. 3A)
interacts specifically with Elp. Elp 1–65 was immobilized
and probed with Gag 27–58 and the R43A mutant peptide.
To maintain peptide solubility and eliminate solvent effects,
1% dimethyl sulfoxide (DMSO) was added to all buffers.
Wt and R43A mutant peptide exhibited comparable inter-
actions with the Elp 1–65 thioredoxin fusion protein and the
thioredoxin control (data not shown). This indicates that
Gag residues 27–58 associate with the thioredoxin domain
and are unlikely to contribute to the Gag-Elp interaction.
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Characterization of N-terminal Gag deletions and the
Gag R43A mutant in the FFV provirus
To determine the function of the FFV Gag Arg43 by
independent techniques, Arg43 was replaced by Ala in the
context of the full-length FFV genome pFeFV-7. In parallel,
increasing sequences from the N-terminus of FFV Gag
(residues 4 to 23 in mutant 1, 4 to 40 in mutant 2, 4 to
62 in mutant 3, and 4 to 97 in mutant 4; see Fig. 3A)
were deleted in the infectious FFV DNA clone. The muta-
tions introduced eliminate in an additive manner conserved
structural motifs predicted by position-specific scoring ma-
trices (Jones, 1999) to exist in all known FV Gag proteins.
For FFV, the conserved structural motifs are an -helix
between Gag residues 7 and 16, two -sheets between
residues 28 and 33 and residues 44 and 52, and a second
-helix between residues 83 and 91 (Fig. 3A).
The mutations introduced into Gag completely abolished
infectivity of the mutants (data not shown) consistent with
the data obtained with the HFV Gag R50A mutant (Eastman
and Linial, 2001). This finding is in contrast to HIV where
the MA domain is, at least under certain circumstances,
dispensable for replication (Reil et al., 1998). Next, the
pattern of gene expression was analyzed 2 days after trans-
Fig. 1. The association of Elp with viral particles is sensitive toward detergent treatment. Feline foamy virus (FFV) particles enriched by centrifugation
through 20% sucrose were incubated at 0°C for 30 min in phosphate-buffered saline lacking (A) or containing 0.5% Triton X-100 (B) and analyzed on
preformed 10 to 32% iodixanol gradients as described. Regular aliquots of the gradient fractions (as indicated) were directly analyzed by immunoblotting
using the FFV-specific cat antiserum 8014. Proteins were detected by enhanced chemoluminescence. Sedimentation was from left (top of the gradient) to right
(bottom). The positions of the p52 and p48 Gag and the FFV Elp proteins are marked. In lanes M, prestained molecular mass markers were separated in
parallel.
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fection into Crandell feline kidney (CRFK) cells. Wt
pFeFV-7-transfected cells expressed substantial amounts of
unprocessed and C-terminally processed FFV Gag p52 and
p48 (Fig. 3B, lane 1). In contrast, cell extracts from the
R43A mutant predominantly contained the unprocessed
R43A Gag protein (lane 4). The N-terminal deletion mu-
tants 1 to 4 expressed truncated Gag molecules of the
expected sizes that were not or only hardly processed at the
C-terminal FFV protease (PR) cleavage site (lanes 5 to 8).
In contrast, processing of the FFV Pol precursor leading to
the FFV PR-RT-RNase H fusion protein of about 70 kDa of
the different mutants was comparable to wt FFV (Fig. 3C,
lanes 1 to 8). Gene expression was reduced in all mutants
possibly due to the loss of infectivity and virus spread. We
then analyzed whether particles are released from 293T
cells transfected with the different Gag mutants. Three days
after transfection, particles were enriched from the cell
culture supernatants by sedimentation through a sucrose
cushion. Whereas structural proteins from virus particles
were easily detectable in the supernatants of wt pFeFV-7-
transfected cells, virion-associated Gag proteins were al-
most undetectable from any of the mutants (data not
shown). The data indicate that the Gag mutations either
completely blocked or drastically reduced the release of
FFV particles.
Subcellular localization of wt and mutant Gag proteins
Since the N-terminal domain of retroviral Gag proteins
plays a critical role in subcellular localization (Freed, 1998),
CRFK cells were transfected with wt and mutant FFV
proviral DNAs and the localization of Gag proteins was
determined by indirect immunofluorescence (IIF) using an
antiserum directed against the C-terminal FFV Gag domain
that had not been affected by the mutations (Fig. 4). FFV
Gag when expressed from the intact proviral genome was
present in the cytoplasm and the perinuclear space of trans-
Fig. 2. The N-terminus of feline foamy virus (FFV) Elp is located inside the intact viral particle. FFV particles enriched by centrifugation through a 20%
sucrose cushion were incubated with and without the subtilisin protease as indicated. Aliquots of the reactions taken in regular intervals were analyzed by
immunoblotting using an antiserum directed against Elp residues 1–30 [underlined in the FFV Env sequence shown at the bottom of the figure (Wilk et al.,
2001)]. Lanes 1 and 2 represent control samples without subtilisin. The samples in lane 2 to 8 were incubated at 37°C for the intervals indicated. Lanes 3
to 7 show the kinetic progression of the subtilisin digestion. Lane 8 represents FFV particles treated for 17 h with subtilisin and subjected to an additional
purification through a 20% sucrose cushion. Due to the sucrose cushion centrifugation, the sample in lane 8 was about five-fold concentrated relative to the
samples in lanes 1 to 7. The positions of the authentic 16-kDa Elp and the about 9-kDa subtilisin-resistant N-terminal fragment of Elp are indicated by arrows.
At the bottom, the N-terminal FFV Env sequence is shown in the single-letter code with the N-terminal 30 residues used for generation of the Elp-specific
serum underlined and the predicted hydrophobic transmembrane anchor in boldface letters.
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fected cells sometimes displaying a punctuated cytosolic
staining (top panel, labeled wt). In contrast, the R43A mu-
tant Gag was almost exclusively present in the nucleus
(bottom panel, R43A). Gag deletion mutants 1 (Gag res-
idues 4–23) and 2 (Gag residues 4–40) exhibited predom-
inantly a nuclear localization with occasional staining in the
cytoplasm whereas mutants 3 and 4 (Gag residues 4–62
and 4–97) were almost exclusively detectable in the nucleus
of the transfected cells (Fig. 4, center panels, 1 to 4). For
the clones analyzed, the pattern of Gag localization was
unchanged between 18 and 42 h after transfection (data not
shown). Subsequently, we studied whether the subcellular
distribution of Gag expressed from an Env-deleted provirus
is changed. The absence of FFV Env did not significantly
alter the cytoplasmic and perinuclear accumulation of wt
Gag indicating that the N-terminal part of Gag intrinsically
directs proper subcellular localization (data not shown).
In parallel, cell fractionation of CRFK cells was per-
formed 3 days after transfection with wt and mutant FFV
genomes. Regular aliquots of cytosolic and nuclear frac-
tions were analyzed by immunoblotting using the FFV CA-
specific serum (Fig. 5). The processed and unprocessed wt
FFV Gag proteins were detectable in the nuclear and cyto-
plasmic fractions (lanes 1 and 2), indicating that the perinu-
clear Gag partitioned into the nuclear fraction. In contrast,
Gag derived from the different deletion clones (lanes 6 to
13) and the R43A mutant (not shown) was almost exclu-
sively present in the nuclear fraction and only trace amounts
were detectable in the cytosol confirming the data obtained
by IIF. In the figure, the samples from wt pFeFV-7-trans-
Fig. 3. Analysis of defined proviral feline foamy virus (FFV) Gag mutants. In the top lines in A, the amino-terminal 100 residues of the FFV Gag are shown
in the single-letter code. Sequences in boldface letters exhibit similarities to a morphogenetic signal in Mason-Pfizer monkey virus Gag and the conserved
Arg residue is marked by a vertical arrow (Eastman and Linial, 2001; Winkler et al., 1997). Sequences corresponding to the wild type (wt) Gag peptide 27–58
are underlined. Below, the R43A substitution mutation is shown in boldface and the Gag sequences deleted in mutants 1 to 4 are marked by hyphens.
Circles represent unmodified residues. The last line presents structural motifs in FFV Gag predicted by position-specific scoring matrices (Jones, 1999). The
following symbols were used: c, coil; h, -helix; e, -sheet. Immunoblot analysis of FFV Gag (B) and Pol proteins (C) expressed from wt and mutant FFV
genomes using a FFV Gag CA- (B) and an FFV protease-specific antiserum (C). Extracts from crandell feline kidney (CRFK) cells transfected with FFV
genomes pFeFV-7 (wt, lane 1), pFeFV-R43A (lane 4), 1 (lane 5), 2 (lane 6), 3 (lane 7), 4 (lane 8), and untreated CRFK cells (mock, lane 3) were
harvested 2 days after transfection. Equal amounts of proteins were applied and Gag- and PR-Pol-specific proteins were detected by enhanced chemolu-
minescence. The positions of the FFV p52Gag and p48Gag and of the Pol precursor and the PR-RT-RNase H fusion protein (with an apparent molecular mass
of about 70 kDa) are marked at the left and right margins, respectively. The positions of prestained molecular mass markers separated in lane 2 are given
at the left-hand margins.
239V. Geiselhart et al. / Virology 310 (2003) 235–244
Fig. 4. Analysis of the subcellular localization of wt and mutant feline foamy virus (FFV) Gag by indirect immunofluorescence (IIF). Crandell feline kidney (CRFK)
cells transfected with the wt FFV genome and Gag mutants 1 to 4 and R43A were processed for IIF 2 days after transfection. Two pairs of representative images
of cells transfected with the wt and mutant FFV genomes and stained with the FFV capsid (CA) antiserum (left-hand panels labeled anti-CA) are shown. The
right-hand panels (labeled anti-CA  DAPI) represent merges of the FFV Gag fluorescence and the nuclear DAPI DNA stain performed in parallel.
fected cells were exposed for a shorter period of time to
compensate for the spread of infectious virus.
Discussion
In this study we provide strong evidence that FFV Elp is
an integral membrane protein with the N-terminus of Env/
Elp oriented toward the interior of the FFV particle. Thus,
and in full agreement with the generally accepted models
for retrovirus particle budding, not only the C-terminus of
the FFV Env transmembrane protein but also the N-termi-
nus of Elp should extend into the cytoplasm of the virus-
producing cell before the particles bud through cellular
membranes. Such a topology of the structural virion protein
Elp that comprises the N-terminal domain of the FV Env
protein has been suggested in a previous study to allow
specific interaction with the Gag-derived MA-layer before
and/or during particle egress from the infected cell (Wilk et
al., 2001). During the characterization of enriched FFV
particles, we detected a second protein from the N-terminus
of Env as a component of virus particles. This Env-specific
protein, p9Env, which also contains the N-terminus of Env,
comigrated with the ca. 9-kDa Elp fragment generated by
subtilisin treatment of FFV particles. According to our data,
subtilisin degrades the C-terminal Elp sequences to the end
of the hydrophobic sequence (boldface letters in the FFV
Env sequence, Fig. 2, bottom) representing the transmem-
brane anchor of Elp. Before the identification and charac-
terization of Elp, a corresponding processing of FV Env by
a cellular signal peptidase to generate a comparably large
signal peptide had been postulated (Wang and Mulligan,
1999). It is thus probable that a highly efficient but presently
unknown processing of Env results in the mature Elp pro-
tein whereas a low-efficient processing by a cellular signal
peptidase yields a comparatively long Env signal peptide
that is also a virion-associated protein. However, alternative
explanations for generation of the 9-kDa Env protein, for
instance as the unglycosylated form of Elp, have been dis-
cussed for HFV, where a corresponding protein has been
also detected (Lindemann et al., 2001). Whereas Elp resi-
dues required for interaction with the MA domain of Gag
are fairly well characterized (Lindemann et al., 2001; Wilk
et al., 2001), it is still open which residues in the N-terminal
part of FV Gag interact with the conserved Trp residues of
Elp. Based on a recent publication where the importance of
a conserved Arg residue at position 50 in HFV Gag was
shown for particle formation and release (Eastman and
Linial, 2001), we reasoned that this Arg could be involved
in interactions with Elp. However, SPR studies using the
N-terminal domain of Elp and Gag 28–57 peptides contain-
ing and lacking the corresponding FFV Gag Arg 43 residue
did not support this conclusion.
As expected and in line with findings presented for HFV
(Eastman and Linial, 2001), the R43A mutation introduced
into the FFV provirus rendered the mutant replication defi-
cient. Whereas wt Gag expressed from the FFV genome had
a mainly perinuclear and cytoplasmic localization, the
R43A mutant FFV Gag was almost entirely present in the
nucleus of transfected cells. Corresponding localization data
were obtained using Gfp-tagged wt and R43A mutant Gag
proteins when analyzed in unfixed, living cells (to be pub-
lished elsewhere). Similarly, FFV mutants with increasing
deletions in the N-terminal part of Gag displayed a gradual
loss of cytoplasmic localization, supporting the assumption
that this part of FV Gag is required for proper localization.
In HFV, wt Gag appears to be exclusively located in the
nucleus of infected cells and mutagenesis of the conserved
Arg50 did not alter the subcellular distribution (Eastman
and Linial, 2001). In contrast, wt FFV and equine FV Gag
Fig. 5. Analysis of Gag localization by cell fractionation and immunobloting. Equal amounts of nuclear (n) and cytoplasmic (c) fractions (as given below
the gel) of crandell feline kidney (CRFK) cells transfected with feline foamy virus (FFV) genomes pFeFV-7 (wt, lanes 1 and 2), 1 (lanes 6 and 7), 2 (lanes
8 and 9), 3 (lanes 10 and 11), 4 (lanes 12 and 13), and untreated CRFK cells (mock, lanes 4 and 5) were harvested 3 days after transfection. The positions
of the FFV p52Gag and p48Gag proteins detected with the CA serum are marked at the left margin. The positions of prestained molecular mass markers
separated in lane 3 are shown. The left part of the image (lanes 1 to 3) was intentionally exposed for a shorter period of time to compensate for the virus
spread derived from wt infectious pFeFV-7 DNA.
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have mainly a cytoplasmic and perinuclear localization with
some nuclear staining (Bodem et al., 1998; Lecellier et al.,
2002), and upon mutagenesis, we demonstrated a relocation
of FFV Gag into the nucleus. The apparently variable cel-
lular distribution of different FV Gag proteins may be re-
lated to the strength of signals regulating cytoplasmic and
nuclear localization, retention, and/or transport. Thus, the
mutations introduced in FFV Gag have altered this balance
to a complete nuclear accumulation or retention.
The correct subcellular distribution of the structural pro-
teins is expected to be a prerequisite for viral morphogen-
esis and the release of viral particles that was abrogated in
all FFV Gag mutants tested. Their altered subcellular dis-
tribution may be also the reason for the severely reduced
proteolytic processing of the mutant Gag proteins. It is
possible that the N-terminal Gag mutations abolished colo-
calization of the Gag substrate and the protease-encoding
Pol proteins directly leading to the strongly reduced Gag
processing. The changes introduced into FFV Gag might
have altered the overall conformation of Gag since the
corresponding mutations in the recombinant Gag 1–154
protein reduced its solubility (data not shown).
It is possible that the N-terminal deletions also affected
other Gag functions, for instance the interaction with Elp.
As a consequence, the increased nuclear localization of
mutant Gag proteins might be also influenced by an abol-
ished interaction of Gag and/or preassembled capsids with
Elp at the cytoplasmic site(s) of virus budding. In this
scenario, the Gag-Elp interactions would serve the functions
of retaining Gag in the cytoplasm and targeting to budding-
competent membranes.
The experimental data presented here and those de-
scribed in the literature are consistent with the model of FV
morphogenesis and budding as previously presented (Wilk
et al., 2001). However, important steps in these processes
and the contribution of cellular factors are presently far
from understood. It is, for instance, completely unknown
how preassembled capsids are targeted to cellular mem-
branes and whether there is specific selection for certain
membranes for FV budding. Independent of these points,
the data available for FVs clearly show that FV morpho-
genesis is different from that of other retroviruses.
Materials and methods
Cell culture, virus propagation, and transfections
293T cells, Crandell feline kidney (CRFK) cells, and
FFV-FAB titration cells were grown as reported previously
and FFV isolate FUV was propagated as described (Winkler
et al., 1997). Transfection of recombinant DNA into 293T
and CRFK cells was performed by the calcium coprecipi-
tation method (Wagner et al., 2000). CRFK cells were also
transfected with Lipofectamine 2000 according to the man-
ufacturer’s instructions (Invitrogen, Groningen, The Neth-
erlands).
Purification of released FFV particles
Cell culture supernatants from FFV-infected CRFK cells
were harvested 4 days post infection (p.i.) when the infected
cells displayed strong virus-induced cytopathic effects
(Winkler et al., 1997), cleared by low-speed centrifugation,
and filtered through 0.45-m pore-size filters (Wilk et al.,
2000). Particles were sedimented through 5 ml of 20%
(wt/vol) sucrose in PBS for 2 h at 24,000 rpm in an SW28
rotor (Beckman, Munich, Germany) and resuspended in
PBS at 4°C.
Additionally, enriched FFV particles were purified and
analyzed by sedimentation into a performed 10 to 32%
iodixanol (Nycomed Pharma, Oslo, Norway) gradient in
TEN (150 mM NaCl, 10 mM Tris/HCl, pH 8.0, 1 mM
EDTA). Sedimentation was in an SW41 rotor (Beckman) at
4°C, 32,000 rpm for 16 h. When indicated, concentrated
FFV virions were resuspended in PBS, adjusted to 0.5%
Triton X-100, incubated on ice for 30 min before loading
onto 10 to 32% iodixanol gradients.
Subtilisin digestion of FFV particles
FFV particles were purified by sedimentation through a
10 to 32% iodixanol gradient. FFV-positive fractions five to
seven were pooled, diluted with PBS, and centrifuged for
2 h at 38,000 rpm in an SW41 rotor. FFV particles were
resuspended in PBS and adjusted to 1 mM CaCl2 and 50
mM Tris/HCl, pH 8.0, subtilisin (Roche, Mannheim) was
added to a final concentration of 10 g/ml, and the samples
were incubated at 37°C (Ott et al., 1995). Aliquots of the
reaction were stopped by addition of phenylmethylsulfonyl
fluoride at regular intervals. The remainder of the subtilisin-
treated FFV virions was sedimented through a 20% sucrose
cushion as described above.
Construction of mutant proviral FFV clones
To delete defined N-terminal segments from the FFV
Gag protein, truncated Gag domains were generated by
polymerase chain reaction (PCR) using the proof-reading
Pfu DNA polymerase as recommended by the supplier
(Stratagene, Heidelberg, Germany). Four different sense prim-
ers Fe-1525 (5-CTACTCGAGGACATGGAGATATTAT-
TGC-3), Fe-1576 (5-GGGCTCGAGGTGATAGATGGGC-
TAG-3), Fe-1642 (5-AGGCTCGAGGATATGATTTG-
GAACC-3), and Fe-1746 (5-CTGCTCGAGGACCT-
GAAAGGCATG-3) [suffixes indicate the 5 end of the
primer in the FFV genome (Winkler et al., 1997), an XhoI
site is underlined] together with anti-sense primer Fe-3039a
(5-GGAGTCCCAGTAACC-3), and pFeFV-7 DNA
(Zemba et al., 2000) were used. Upon subcloning of the
PCR products, the four amplicons were excised with XhoI
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and Bpu1102I (at the 3 end of each amplicon), gel-purified,
and inserted into the correspondingly digested infectious
FFV DNA clone pFeFV-7. Positive clones were identified
by restriction enzyme digestion and designated as Gag de-
letion mutants 1 (residue 4–23), 2 (residue 4–40), 3
(residue 4–62), and 4 (residue 4–97).
To substitute Arg43 of FFV Gag by an Ala residue in the
infectious FFV provirus, a fusion PCR-mediated mutagen-
esis was performed as described previously (Alke et al.,
2001). FFV Gag sequences were amplified by Pfu polymer-
ase with primers GagATG (5-GGACTAGTATGGCTC-
GAGAATTAAATCCTCTCC-3; Bodem et al., 1998) plus
RAa (5-CTAGCCCATGCATCACCTGGACCCCAAG-
3), (the altered residues are marked in boldface letters, an
introduced NsiI site by underlining) and RAs (5-CAGGT-
GATGCATGGGCTAGAGTGACAAT-3) plus Fe-3039a
using cloned pFeFV-7 DNA as template. The gel-purified
PCR products were combined and used as template for a
third PCR using the external primers GagATG and Fe-
3039a. The amplicon of about 1570 nucleotides was di-
gested with XhoI and Bpu1 102I and inserted into the
correspondingly digested FFV genome pFeFV-7. Indepen-
dent correct clones were identified and designated pFeFV-
R43A.
Recombinant protein expression, purification, and
antiserum production
FFV Gag residues 224 to 514 were amplified by PCR
with primers 5-CATGCCATGGCCTTAGTAGCATCT-
CATCC-3 (introduced NcoI site underlined) and 5-
CGGGATCCTAATCTTTACCCCCTTTCTT-3 (introduced
BamHI site underlined) as described previously (Alke et al.,
2001) and the amplicon was subcloned into pCR2.1-TOPO
(Invitrogen, Karlsruhe, Germany). The Gag sequence was
excised with NcoI and BamHI and inserted into a corre-
spondingly digested vector pET24d derivative (Novagen,
Madison, USA). The recombinant protein of about 35 kDa
was insoluble in induced E. coli BL-21 cells and thus
purified by preparative gel electrophoresis and elution using
the Mini Whole Gel Eluter as suggested by the manufac-
turer (BioRad, Munich, Germany). The purified Gag 224–
514 protein was used for immunization of guinea-pigs by
Eurogentec (Seraing, Belgium).
Immunoblotting and indirect immunofluorescence IIF
Cell fractionation of transfected CRFK cells was done as
described recently (Lecellier et al., 2002). In brief, adherent
cells were incubated in lysis buffer (50 mM Tris/HCl, pH
7.4, 0.1 M NaCl, 5 mM MgCl2, 1% Triton X-100, 0.5%
Na-deoxycholate, 0.05% sodium dodecyl sulfate, 1 mM
phenylmethylsulfonyl fluoride) on ice for 30 min. Lysed
cells were harvested with a rubber policemen and centri-
fuged at 12,000 rpm, 5 min, 4°C. The supernatants repre-
senting the cytosolic and the pellets corresponding to the
nuclear fractions were adjusted to the same volume and
analyzed by immunoblotting. Immunoblotting of proteins
separated on denaturing gels and detection of specifically
bound antibodies by enhanced chemoluminescence was
done as described previously (Winkler et al., 1997). The
FFV Elp and cat 8014 antisera were used as described (Alke
et al., 2000; Wilk et al., 2001). For IIF, CRFK cells were
grown and transfected on coverslips, washed with PBS
containing 1 mM MgCl2, and fixed in methanol containing
0.02% (wt/vol) EGTA for at least 1 h at 20°C (Schwantes
et al., 2002). Staining of FFV Gag was done with the
antisera described above for 45 min at room temperature at
a 1:2,000 dilution in PBS containing 3% bovine serum
albumin. After washing, a secondary Cy2-labeled antibody
(Dianova, Hamburg, Germany) was used and the samples
were mounted in Mowiol (Calbiochem, La Jolla, CA, USA)
on microscopic slides (Schwantes et al., 2002). Microscopy
was performed with a DMRBE microscope (Leica, Wetzlar,
Germany). Images taken with a Hamamatsu digital camera
and camera controller C4742-95 (Hamamatsu Photonics,
Herrsching, Germany) were analyzed with the Openlab pro-
gram (Improvision, Heidelberg, Germany).
Binding analysis by surface plasmon resonance (SPR)
Protein interaction studies were performed by SPR tech-
nology using the BIAcore 3000 instrument (BIAcore,
Freiburg, Germany) as described previously (Wilk et al.,
2001). Elp residues 1 to 65 were expressed as a thioredoxin
and HisTag fusion protein and purified by Ni-affinity chro-
matography as described (Wilk et al., 2001). The homoge-
neity of the soluble recombinant protein was in the range of
90%. Before usage, the purified protein was dialysed against
PBS. The Elp 1–65 thioredoxin fusion protein and the
thioredoxin control protein were coupled to a CM 5 sensor
chip. The Gag 27–58 wt and R43A peptides were dissolved
in HBS-EP containing 1% DMSO. For all measurements,
1% DMSO was also added to the running buffer HBS-EP
(10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA,
0.005% surfactant P20). The chip was regenerated with 3 M
guanidinium, 5 mM glycin, pH 3.0.
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